Biologic Specimen and Data Repository Information Coordinating Center

New Study: CureSC-SCD (specimens)

A new study, Cure Sickle Cell Hematopoietic Stem Cell Collection (CureSC-SCD), has been posted to BioLINCC. Specimens from this study are available for requests.

PETAL-ROSE Biospecimens Available

Biospecimens from the Prevention and Early Treatment of Acute Lung Injury (PETAL) Network – Reevaluation of Systemic Early Neuromuscular Blockade (ROSE) study are now available for request.

New Study: DISC06 (data and specimens)

A new study, Dietary Intervention Study in Children Follow-Up Study (DISC06), has been posted to BioLINCC. Data and specimens from this study are available for requests.

PETAL-VIOLET Biospecimens Available

Biospecimens from the Prevention and Early Treatment of Acute Lung Injury (PETAL) Clinical Trials Network – Vitamin D to Improve Outcomes by Leveraging Early Treatment (VIOLET) study are now available for request.

AsthmaNet Biospecimens Available (8 studies)

Biospecimens from 8 AsthmaNet studies are now available for request.

This includes the AsthmaNet Proof of Concept Study of Alendronate for Asthma (ALFA), AsthmaNet Azithromycin for Preventing the Development of Upper Respiratory Tract Illness Into Lower Respiratory Tract Symptoms in Children (APRIL) and Oral Corticosteroids for Treating Episodes of Significant Lower Respiratory Tract Symptoms in Children (OCELOT), AsthmaNet Best African American Response to Asthma Drugs (BARD), AsthmaNet Individualized Therapy For Asthma in Toddlers (INFANT) and Acetaminophen Versus Ibuprofen in Children With Asthma (AVICA), AsthmaNet Airway Microbiome in Asthma: Relationships to Asthma Phenotype and Inhaled Corticosteroid Treatment, AsthmaNet Steroids in Eosinophil Negative Asthma (SIENA), AsthmaNet Step-up Yellow Zone Inhaled Corticosteroids to Prevent Exacerbations (STICS), and AsthmaNet Vitamin D Add-on Therapy Enhances Corticosteroid Responsiveness in Asthma (VIDA) studies.

Funding Opportunity: PAR-23-036 Secondary Analysis of Existing Datasets in Heart, Lung, and Blood Diseases and Sleep Disorders (R21)

This Funding Opportunity Announcement (FOA) encourages R21 applications that propose to conduct secondary analyses using existing human datasets in areas relevant to the National Heart, Lung, Blood Diseases and Sleep Disorders Institute (NHLBI) scientific mission. The FOA aims to stimulate the use of existing human datasets to investigate novel scientific ideas, and/or generate new models, systems, tools, or technologies that have the potential for significant impact on biomedical or biobehavioral research. Generation of new primary data is not allowed.

For more information on PAR-23-036 please visit:
https://grants.nih.gov/grants/guide/pa-files/PAR-23-036.html

PETAL-BLUE CORAL Biospecimens Available

Biospecimens from the Prevention and Early Treatment of Acute Lung Injury (PETAL) Network – Biology and Longitudinal Epidemiology of PETAL COVID-19 Observational Study (BLUE CORAL) study are now available for request.

New Study: PETAL-FIRE CORAL (data and specimens)

A new study, Prevention and Early Treatment of Acute Lung Injury (PETAL) Network – Functional, imaging, and respiratory evaluation in CORAL (FIRE CORAL), has been posted to BioLINCC. Data and specimens from this study are available for requests.

Funding Opportunity: NHLBI R21 RFA-HL-23-018

This funding opportunity is to support meritorious exploratory research relevant to the NHLBI mission using the biospecimen collections that are stored in the NHLBI Biorepository and that are available through BioLINCC. The first application due date is June 21, 2022.

For more information on RFA-HL-23-018 please visit: https://grants.nih.gov/grants/guide/rfa-files/RFA-HL-23-018.html

as well as the FAQs: https://www.nhlbi.nih.gov/grants-and-training/funding-opportunities-and-contacts/RFA-HL-23-018

To view RFA-HL-23-018 funded projects please visit NIH RePORTER